The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia

Journal of Clinical Virology

Volumn 58, Issue 1, 2013, Pages 54-58

  Milosevic, Ivana ^a   Delic, Dragan ^a   Lazarevic, Ivana ^a   Pavlovic, Ivana Pesic ^a   Korac, Milos ^a   Bojovic, Ksenija ^a   Jevtovic, Djordje ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Genotypes; HBV; Prognosis

Indexed keywords

HEPATITIS B ANTIGEN; LAMIVUDINE;

ADULT; AND OVERALL ESTIMATED MEAN SURVIVAL; ARTICLE; COHORT ANALYSIS; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; SERBIA; TREATMENT OUTCOME; VIRUS LOAD;

EID: 84881542041     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.06.017     Document Type: Article

References (18)

1. Kao J.H. Molecular epidemiology of hepatitis B. Korean J Intern Med 2011, 26:255-261.
2. Lazarevic I., Cupic M., Delic D., Svirtlih S.N., Simonovic J., Jovanovic T. Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia. Arch Virol 2007, 152:2017-2025.
3. EASL Clinical Practice Guidelines Management of chronic hepatitis B virus infection. J Hepatol 2012, 57:167-185.
4. Deterding K., Constantinescu I., Nedelcu F.D., Gervain J., Nemecek V., Srtunecky O., et al. Prevalence of HBV genotypes in Central and Eastern Europe. J Med Virol 2008, 80:1707-1711.
5. Iloeje U.H., Yang H.I., Chen C.J. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?. Liver Int 2012, 32:1333-1341.
6. Walsh R., Locarnini S. Hepatitis B precore protein: pathogenic potential and therapeutic promise. Yonsei Med J 2012, 53:875-885.
7. Vutien P., Trinh H.N., Nguyen K., Garcia R.T., Nguyen H.A., Levitt B.S., et al. Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B. Aliment Pharmacol Ther 2013, 37:464-472.
8. Tanwar S., Dusheiko G. Is there any value to hepatitis B virus genotype analysis?. Curr Gastroenterol Rep 2012, 14:37-46.
9. Lin C.L., Kao J.H. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 2011, 26:S123-S130.
10. McMahon B. Natural history of chronic hepatitis B - clinical implications. Medscape J Med 2008, 10:91.
11. Milich D., Liang T.J. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003, 38:1075-1086.
12. Sánchez-Tapias J.M., Costa J., Mas A., Bruguera M., Rodés J. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 2002, 123:1848-1856.
13. Kobayashi M., Arase Y., Ikeda K., Tsubota A., Suzuki Y., Saitoh S., et al. Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C. J Gastroenterology 2002, 37:35-39.
14. Chu C.J., Keeffe E.B., Han S.H., Perrillo R.P., Min A.D., Soldevila-Pico C. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 2003, 125:444-451.
15. Kumar A., Kumar S.I., Pandey R., Naik S., Aggarwal R. Hepatitis B virus genotype A is more often associated with severe liver disease in northern India than is genotype D. Indian J Gastroenterol 2005, 24:19-22.
16. Yang H.I., Lu S.N., Liaw Y.F., You S.L., Sun C.A., Wang L.Y., et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002, 347:168-174.
17. Malmström S., Eilard A., Larsson S.B., Hannoun C., Norkrans G., Lindh M. Genotype impact on long-term virological outcome of chronic hepatitis B virus infection. J Clin Virol 2012, 54:321-326.
18. Zalewska M., Domagala M., Simon K., Gladysz A. Hepatitis B virus genotypes and the response to lamivudine therapy. Pol Arch Med Wewn 2005, 114:1190-1199.